{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:57:24Z","timestamp":1778626644026,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41390-019-0628-9","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T08:03:04Z","timestamp":1574409784000},"page":"669-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro"],"prefix":"10.1038","volume":"87","author":[{"given":"Rebecca","family":"P\u00f6tschke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Kramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Henning","family":"Klusmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"H\u00fcttelmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caspar D.","family":"K\u00fchn\u00f6l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"628_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","volume":"107","author":"DR Johnson","year":"2012","unstructured":"Johnson, D. R. & O\u2019Neill, B. P. Glioblastoma survival in the United States before and during the temozolomide era. J. Neurooncol. 107, 359\u2013364 (2012).","journal-title":"J. Neurooncol."},{"key":"628_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492\u2013507 (2008).","journal-title":"N. Engl. J. Med."},{"key":"628_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/pbc.22566","volume":"55","author":"JE Wolff","year":"2010","unstructured":"Wolff, J. E. et al. Measuring performance status in pediatric patients with brain tumors-experience of the HIT-GBM-C protocol. Pediatr. Blood Cancer 55, 520\u2013524 (2010).","journal-title":"Pediatr. Blood Cancer"},{"key":"628_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/neuonc\/noq191","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen, K. J. et al. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children\u2019s Oncology Group. Neuro Oncol. 13, 317\u2013323 (2011).","journal-title":"Neuro Oncol."},{"key":"628_CR5","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00381-012-1890-x","volume":"28","author":"KK Das","year":"2012","unstructured":"Das, K. K. et al. Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome. Childs Nerv. Syst. 28, 2055\u20132062 (2012).","journal-title":"Childs Nerv. Syst."},{"key":"628_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11060-007-9495-z","volume":"87","author":"JE Wolff","year":"2008","unstructured":"Wolff, J. E. et al. Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. J. Neurooncol. 87, 155\u2013164 (2008).","journal-title":"J. Neurooncol."},{"key":"628_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1215\/15228517-2008-092","volume":"11","author":"V Suri","year":"2009","unstructured":"Suri, V. et al. Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol. 11, 274\u2013280 (2009).","journal-title":"Neuro Oncol."},{"issue":"5B","key":"628_CR8","first-page":"3773","volume":"26","author":"CM Kramm","year":"2006","unstructured":"Kramm, C. M. et al. Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res. 26(5B), 3773\u20133779 (2006).","journal-title":"Anticancer Res."},{"key":"628_CR9","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/molecules20033898","volume":"20","author":"M Mottamal","year":"2015","unstructured":"Mottamal, M. et al. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules 20, 3898\u20133941 (2015).","journal-title":"Molecules"},{"key":"628_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","volume":"86","author":"CA Barker","year":"2013","unstructured":"Barker, C. A. et al. Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int. J. Radiat. Oncol. Biol. Phys. 86, 504\u2013509 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11060-014-1713-x","volume":"122","author":"AN Hosein","year":"2015","unstructured":"Hosein, A. N. et al. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells. J. Neurooncol. 122, 263\u2013271 (2015).","journal-title":"J. Neurooncol."},{"key":"628_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","volume":"107","author":"KA Van Nifterik","year":"2012","unstructured":"Van Nifterik, K. A. et al. Valproic acid sensitizes human glioma cells for temozolomide and gamma-radiation. J. Neurooncol. 107, 61\u201367 (2012).","journal-title":"J. Neurooncol."},{"key":"628_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller, M. et al. Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma. Neurology 77, 1156\u20131164 (2011).","journal-title":"Neurology"},{"key":"628_CR14","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821\u20135828 (2003).","journal-title":"Cancer Res."},{"key":"628_CR15","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.2036535100","volume":"100","author":"HD Hemmati","year":"2003","unstructured":"Hemmati, H. D. et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA 100, 15178\u201315183 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"628_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000017435","volume":"22","author":"Y Kaneko","year":"2000","unstructured":"Kaneko, Y. et al. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev. Neurosci. 22, 139\u2013153 (2000).","journal-title":"Dev. Neurosci."},{"key":"628_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1006\/dbio.1996.0130","volume":"176","author":"S Sakakibara","year":"1996","unstructured":"Sakakibara, S. et al. Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev. Biol. 176, 230\u2013242 (1996).","journal-title":"Dev. Biol."},{"key":"628_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-221","volume":"9","author":"XY Wang","year":"2010","unstructured":"Wang, X. Y. et al. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol. Cancer 9, 221 (2010).","journal-title":"Mol. Cancer"},{"key":"628_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.18632\/oncotarget.1034","volume":"4","author":"XY Wang","year":"2013","unstructured":"Wang, X. Y. et al. Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer. Oncotarget 4, 739\u2013750 (2013).","journal-title":"Oncotarget"},{"key":"628_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1432-0436.2001.680208.x","volume":"68","author":"Y Kanemura","year":"2001","unstructured":"Kanemura, Y. et al. Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity. Differentiation 68, 141\u2013152 (2001).","journal-title":"Differentiation"},{"key":"628_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000103307","volume":"43","author":"A Nakano","year":"2007","unstructured":"Nakano, A. et al. Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors. Pediatr. Neurosurg. 43, 279\u2013284 (2007).","journal-title":"Pediatr. Neurosurg."},{"key":"628_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11060-013-1246-8","volume":"115","author":"RH Dahlrot","year":"2013","unstructured":"Dahlrot, R. H. et al. Prognostic value of Musashi-1 in gliomas. J. Neurooncol. 115, 453\u2013461 (2013).","journal-title":"J. Neurooncol."},{"key":"628_CR23","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1128\/MCB.21.12.3888-3900.2001","volume":"21","author":"T Imai","year":"2001","unstructured":"Imai, T. et al. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell. Biol. 21, 3888\u20133900 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"628_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mcn.2005.09.003","volume":"31","author":"C Battelli","year":"2006","unstructured":"Battelli, C. et al. The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol. Cell. Neurosci. 31, 85\u201396 (2006).","journal-title":"Mol. Cell. Neurosci."},{"key":"628_CR25","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1002\/stem.2202","volume":"33","author":"FM Cambuli","year":"2015","unstructured":"Cambuli, F. M. et al. A mouse model of targeted musashi1 expression in whole intestinal epithelium suggests regulatory roles in cell cycle and stemness. Stem Cells 33, 3621\u20133634 (2015).","journal-title":"Stem Cells"},{"key":"628_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2741\/3915","volume":"17","author":"RI Glazer","year":"2012","unstructured":"Glazer, R. I., Vo, D. T. & Penalva, L. O. Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front. Biosci. (Landmark Ed.) 17, 54\u201364 (2012).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"628_CR27","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1073\/pnas.0600906103","volume":"103","author":"NA Siddall","year":"2006","unstructured":"Siddall, N. A. et al. The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity. Proc. Natl Acad. Sci. USA 103, 8402\u20138407 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"628_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrclinonc.2012.87","volume":"9","author":"C Jones","year":"2012","unstructured":"Jones, C., Perryman, L. & Hargrave, D. Paediatric and adult malignant glioma: close relatives or distant cousins? Nat. Rev. Clin. Oncol. 9, 400\u2013413 (2012).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"628_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-015-0266-3","volume":"3","author":"TA Jones","year":"2015","unstructured":"Jones, T. A. et al. Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-kappaB pathways. Acta Neuropathol. Commun. 3, 86 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"628_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5455\/jice.20140123040224","volume":"3","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from Corydalis yanhusuo W. T. Wang. J. Intercult. Ethnopharmacol. 3, 68\u201372 (2014).","journal-title":"J. Intercult. Ethnopharmacol."},{"key":"628_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2176\/nmc.27.581","volume":"27","author":"I Takeshita","year":"1987","unstructured":"Takeshita, I. et al. Characteristics of an established human glioma cell line, KNS-42. Neurol. Med. Chir. (Tokyo) 27, 581\u2013587 (1987).","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"628_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1158\/2159-8290.CD-12-0426","volume":"3","author":"L Bjerke","year":"2013","unstructured":"Bjerke, L. et al. Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov. 3, 512\u2013519 (2013).","journal-title":"Cancer Discov."},{"key":"628_CR33","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1158\/0008-5472.CAN-10-1250","volume":"70","author":"N Gaspar","year":"2010","unstructured":"Gaspar, N. et al. MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX\/stem cell gene signature. Cancer Res. 70, 9243\u20139252 (2010).","journal-title":"Cancer Res."},{"key":"628_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-1-r14","volume":"15","author":"B Kechavarzi","year":"2014","unstructured":"Kechavarzi, B. & Janga, S. C. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 15, R14 (2014).","journal-title":"Genome Biol."},{"key":"628_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"B Pereira","year":"2017","unstructured":"Pereira, B., Billaud, M. & Almeida, R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer 3, 506\u2013528 (2017).","journal-title":"Trends Cancer"},{"key":"628_CR36","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1158\/1078-0432.CCR-16-2728","volume":"23","author":"AE Kudinov","year":"2017","unstructured":"Kudinov, A. E. et al. Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets. Clin. Cancer Res. 23, 2143\u20132153 (2017).","journal-title":"Clin. Cancer Res."},{"key":"628_CR37","doi-asserted-by":"crossref","first-page":"42485","DOI":"10.18632\/oncotarget.9890","volume":"7","author":"HY Chen","year":"2016","unstructured":"Chen, H. Y. et al. Musashi-1 regulates AKT-derived IL-6 autocrinal\/paracrinal malignancy and chemoresistance in glioblastoma. Oncotarget 7, 42485\u201342501 (2016).","journal-title":"Oncotarget"},{"key":"628_CR38","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ajpath.2016.05.020","volume":"186","author":"PR de Araujo","year":"2016","unstructured":"de Araujo, P. R. et al. Musashi1 impacts radio-resistance in glioblastoma by controlling DNA-protein kinase catalytic subunit. Am. J. Pathol. 186, 2271\u20132278 (2016).","journal-title":"Am. J. Pathol."},{"key":"628_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3109\/08880018.2011.563774","volume":"28","author":"FH Felix","year":"2011","unstructured":"Felix, F. H. et al. Potential role for valproate in the treatment of high-risk brain tumors of childhood-results from a retrospective observational cohort study. Pediatr. Hematol. Oncol. 28, 556\u2013570 (2011).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"628_CR40","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1080\/15476286.2018.1539607","volume":"15","author":"C Yi","year":"2018","unstructured":"Yi, C. et al. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. RNA Biol. 15, 1420\u20131432 (2018).","journal-title":"RNA Biol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0628-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:29Z","timestamp":1684618109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0628-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0628-9","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}